|
|||||
|
|
Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high‐risk patients with diffuse large B‐cell lymphoma |
|
| Authors: | Jeremy S. Abramson MD Ephraim P. Hochberg MD |
| Affiliation: | 1. Center for Lymphoma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts;2. Department of Medicine, Harvard Medical School, Boston, Massachusetts |
| Abstract: | |
| Keywords: | |